Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins.
paper
Cited
Public
Unavailable
- Authors
- Kendler, Kenneth S; Jacobson, Kristen C; Prescott, Carol A; Neale, Michael C
- Year
- 2003
- Journal
- The American journal of psychiatry
- PMID
- 12668357
- DOI
- 10.1176/appi.ajp.160.4.687
OBJECTIVE: Data on use and misuse of six classes of illicit substances by male twin pairs were used to examine whether genetic and shared environmental risk factors for substance use disorders are substance-specific or -nonspecific in their effect. METHOD: Lifetime history of use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates was assessed at personal interview in both members of 1,196 male-male twin pairs ascertained by the Virginia Twin Registry. Multivariate twin modeling of substance-nonspecific (common) and substance-specific genetic, shared environmental, and unique environmental risk factors was performed by using the program Mx. RESULTS: High levels of comorbidity involving the different substance categories were observed for both use and abuse/dependence. One common genetic factor was found to have a strong influence on risk for illicit use and abuse/dependence for all six substance classes. A modest influence of substance-specific genetic factors was seen for use but not for abuse/dependence. Shared environmental factors were more important for use than for abuse/dependence and were mediated entirely through a single common factor. CONCLUSIONS: In an adult population-based sample of male twins, both the genetic and the shared environmental effects on risk for the use and misuse of six classes of illicit substances were largely or entirely nonspecific in their effect. Environmental experiences unique to the person largely determine whether predisposed individuals will use or misuse one class of psychoactive substances rather than another.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Environmental Enrichment Attenuates Fentanyl-Seeking Behavior and Protects against Stress-Induced Reinstatement in Both Male and Female Rats. | Higginbotham JA et al. | β | 2026 | β |
| Genome-wide meta-analyses of cross substance use disorders in diverse populations. | Lai D et al. | β | 2026 | β |
| Multivariate genetic analyses of 2.2 million individuals reveal broad and substance-specific pathways of addiction risk. | Poore HE et al. | β | 2026 | β |
| Parental death and parental substance use problems during childhood and the risk of DSM-5 substance use, suicidality and mental health disorders. | Giang CW et al. | β | 2026 | β |
| The Impact of a Registry-Based Environmental Risk Score on Episodes of Alcohol Use Disorder and Drug Use Disorder in Swedish National Samples. | Kendler KS et al. | β | 2026 | β |
| "General Addiction Liability" Revisited. | Watts AL et al. | β | 2025 | β |
| Genetic influences for distinct impulsivity domains are differentially associated with early substance use initiation: Results from the ABCD Study. | Kinstler E et al. | β | 2025 | β |
| Identification of variants from gene expression data of opioid-addicted patients. | Ajmeriya S et al. | β | 2025 | β |
| Identifying compounds to treat opiate use disorder by leveraging multi-omic data integration and multiple drug repurposing databases. | Stratford JK et al. | β | 2025 | β |
| Inbred rat heredity and sex affect oral oxycodone self-administration and augmented intake in long sessions: correlations with anxiety and novelty-seeking. | Sharp BM et al. | β | 2025 | β |
| Paternal heroin self-administration in rats increases drug-seeking behavior in male offspring via miR-19b downregulation in the nucleus accumbens. | Gao W et al. | β | 2025 | β |
| Validation studies and multiomics analysis of Zhx2 as a candidate quantitative trait gene underlying brain oxycodone metabolite (oxymorphone) levels and behavior. | Lynch WB et al. | β | 2025 | β |
| A Bivariate Twin Study of Lifetime cannabis Initiation and Lifetime Regular Tobacco Smoking Across Three Different Countries. | Zellers S et al. | β | 2024 | β |
| Associations of adolescent substance use and depressive symptoms with adult major depressive disorder in the United States: NSDUH 2016-2019. | Xu C et al. | β | 2024 | β |
| Causation and Common Liability in the Progression of the U.S. Opioid Crisis. | Dash GF et al. | β | 2024 | β |
| Decoding cocaine-induced proteomic adaptations in the mouse nucleus accumbens. | Mews P et al. | β | 2024 | β |
| Differential etiologic associations of heroin use and prescription opioid misuse with psychopathology. | Dash GF et al. | β | 2024 | β |
| Generalized genetic liability to substance use disorders. | Miller AP et al. | β | 2024 | β |
| Media framings of the role of genomics in "addiction" in the United States from 2015 to 2019: Individualized risk, biomedical expertise, and the limits of destigmatization. | Hendy K | β | 2024 | β |
| Molecular and Environmental Determinants of Addictive Substances. | Lorek M et al. | β | 2024 | β |
| Opioid use disorder in pediatric populations: considerations for perioperative pain management and precision opioid analgesia. | Chen YH et al. | β | 2024 | β |
| SNP-based and haplotype-based genome-wide association on drug dependence in Han Chinese. | Xu H et al. | β | 2024 | β |
| Stigmata that are desired: Contradictions in addiction. | Vanyukov MM | β | 2024 | β |
| A multivariate approach to understanding the genetic overlap between externalizing phenotypes and substance use disorders. | Poore HE et al. | β | 2023 | β |
| A review of the genomics of neonatal abstinence syndrome. | Yen E et al. | β | 2023 | β |
| Association of GABA receptor delta subunit gene variations with increased risk of methamphetamine dependence. | Xie X et al. | β | 2023 | β |
| Caring for Our Patients With Opioid Use Disorder in the Perioperative Period: A Guide for the Anesthesiologist. | Barreveld AM et al. | β | 2023 | β |
| Is Asian flushing syndrome a disadvantage in the labor market? | Kawaguchi D et al. | β | 2023 | β |
| Military service and risk of subsequent drug use disorders among Swedish men. | Edwards AC et al. | β | 2023 | β |
| Modeling the normal:abnormal spectrum of early childhood internalizing behaviors: A clinical-developmental approach for the Multidimensional Assessment Profiles Internalizing Dimensions. | Wakschlag LS et al. | β | 2023 | β |
| N-acetyltransferase 2 genetic polymorphism modifies genotoxic and oxidative damage from new psychoactive substances. | Salazar-GonzΓ‘lez RA et al. | β | 2023 | β |
| Repeated dosing with cocaine produces strain-dependent effects on responding for conditioned reinforcement in Collaborative Cross mice. | Bailey LS et al. | β | 2023 | β |
| Risk assessment of substance use disorders based on the human leukocyte antigen (HLA). | James LM et al. | β | 2023 | β |
| Shared genetic and environmental etiology between substance use disorders and suicidal behavior. | Edwards AC et al. | β | 2023 | β |
| Single nucleus transcriptomics of ventral midbrain identifies glial activation associated with chronic opioid use disorder. | Wei J et al. | β | 2023 | β |
| Specificity in genetic and environmental risk for prescription opioid misuse and heroin use. | Dash GF et al. | β | 2023 | β |
| Substance use disorder is the outcome of deviant socialization: A prospective investigation spanning childhood to adulthood. | Reynolds M et al. | β | 2023 | β |
| Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention. | Volkow ND et al. | β | 2023 | β |
| The Concept of Resistance to Substance Use and a Research Approach: The Resist! Project. | Vanyukov MM et al. | β | 2023 | β |
| The Interrelationship of the Genetic Risks for Different Forms of Substance Use Disorder in a Swedish National Sample: A Top-Down Genetic Analysis. | Kendler KS et al. | β | 2023 | β |
| Are prescription misuse and illicit drug use etiologically distinct? A genetically-informed analysis of opioids and stimulants. | Dash GF et al. | β | 2022 | β |
| Clinical, environmental, and genetic risk factors for substance use disorders: characterizing combined effects across multiple cohorts. | Barr PB et al. | β | 2022 | β |
| Cocaine Use Disorder (CUD): Current Clinical Perspectives. | Schwartz EKC et al. | β | 2022 | β |
| Contextualizing prescription opioid misuse and heroin use within dimensional models of drug involvement. | Dash GF et al. | β | 2022 | β |
| Cross-ancestry meta-analysis of opioid use disorder uncovers novel loci with predominant effects in brain regions associated with addiction. | Kember RL et al. | β | 2022 | β |
| Endogenous opioid systems alterations in pain and opioid use disorder. | Higginbotham JA et al. | β | 2022 | β |
| FOXN3 and GDNF Polymorphisms as Common Genetic Factors of Substance Use and Addictive Behaviors. | Vereczkei A et al. | β | 2022 | β |
| Integrating human brain proteomic data with genome-wide association study findings identifies novel brain proteins in substance use traits. | Toikumo S et al. | β | 2022 | β |
| Methylation of the serotonin transporter gene moderates the depressive subjective effect of cocaine. | Longtain RB et al. | β | 2022 | β |
| Molecular genetics of cocaine use disorders in humans. | FernΓ ndez-Castillo N et al. | β | 2022 | β |
| Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond. | Gaddis N et al. | β | 2022 | β |
| Pairwise genetic meta-analyses between schizophrenia and substance dependence phenotypes reveals novel association signals with pharmacological significance. | Greco LA et al. | β | 2022 | β |
| Polysubstance Use, Mood Disorders, and Chronic Conditions With Anxiety in Opioid Patients. | Liu S et al. | β | 2022 | β |
| Predicting the Onset of Opioid Use Disorder in the Swedish General Population. | Kendler KS et al. | β | 2022 | β |
| Social Determinants of Inter-Individual Variability and Vulnerability: The Role of Dopamine. | Faure P et al. | β | 2022 | β |
| Survey of Opioid Risk Tool Among Cancer Patients Receiving Opioid Analgesics. | Oh SY et al. | β | 2022 | β |
| The genetic aetiology of cannabis use: from twin models to genome-wide association studies and beyond. | Verweij KJH et al. | β | 2022 | β |
| The Ratio of Second and Fourth Digit Length: A Biomarker for Methamphetamine Dependence? | Kim Y et al. | β | 2022 | β |
| Zhx2 Is a Candidate Gene Underlying Oxymorphone Metabolite Brain Concentration Associated with State-Dependent Oxycodone Reward. | Beierle JA et al. | β | 2022 | β |
| Addiction as a brain disease revised: why it still matters, and the need for consilience. | Heilig M et al. | β | 2021 | β |
| Alcohol substitution during one month of cannabis abstinence among non-treatment seeking youth. | Schuster RM et al. | β | 2021 | β |
| A systems omics-based approach to decode substance use disorders and neuroadaptations. | Veerappa A et al. | β | 2021 | β |
| Cross-ancestry meta-analysis of opioid use disorder uncovers novel loci with predominant effects on brain | Kember RL et al. | β | 2021 | β |
| Differential behavioral functioning in the offspring of rats with high vs. low self-administration of the opioid agonist remifentanil. | Rezvani AH et al. | β | 2021 | β |
| Early Life Stress and Risks for Opioid Misuse: Review of Data Supporting Neurobiological Underpinnings. | Oswald LM et al. | β | 2021 | β |
| Epigenetics of Drug Addiction. | Stewart AF et al. | β | 2021 | β |
| Genetics of substance use disorders: a review. | Deak JD et al. | β | 2021 | β |
| Genome-Wide Correlation of DNA Methylation and Gene Expression in Postmortem Brain Tissues of Opioid Use Disorder Patients. | Liu A et al. | β | 2021 | β |
| Identification of novel risk loci with shared effects on alcoholism, heroin, and methamphetamine dependence. | Sun Y et al. | β | 2021 | β |
| Marijuana Legalization in Colorado: Increasing Potency, Changing Risk Perceptions, and Emerging Public Health Concerns for Youth. | Hinckley JD et al. | β | 2021 | β |
| Risk Assessment for Heroin Use and Craving Score Using Polygenic Risk Score. | Huang CL et al. | β | 2021 | β |
| Sex and heredity are determinants of drug intake in a novel model of rat oral oxycodone self-administration. | Sharp BM et al. | β | 2021 | β |
| The Association between a MAOB Variable Number Tandem Repeat Polymorphism and Cocaine and Opiate Addictions in Polyconsumers. | Mateu C et al. | β | 2021 | β |
| The Genomics of Opioid Addiction Longitudinal Study (GOALS): study design for a prospective evaluation of genetic and non-genetic factors for development of and recovery from opioid use disorder. | Heil J et al. | β | 2021 | β |
| Adolescent Externalizing Psychopathology and Its Prospective Relationship to Marijuana Use Development from Age 14 to 30: Replication Across Independent Longitudinal Twin Samples. | Zellers SM et al. | β | 2020 | β |
| Analysis of substance use and its outcomes by machine learning: II. Derivation and prediction of the trajectory of substance use severity. | Hu Z et al. | β | 2020 | β |
| An update on the role of common genetic variation underlying substance use disorders. | Johnson EC et al. | β | 2020 | β |
| A positive association between a polymorphism in the <i>HTR2B</i> gene and cocaine-crack in a French Afro-Caribbean population. | Lacoste J et al. | β | 2020 | β |
| Association Between Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Methamphetamine Use Disorder: A Meta-Analysis. | He L et al. | β | 2020 | β |
| Association studies of dopamine synthesis and metabolism genes with multiple phenotypes of heroin dependence. | Li Y et al. | β | 2020 | β |
| Contribution of D1R-expressing neurons of the dorsal dentate gyrus and Ca<sub>v</sub>1.2 channels in extinction of cocaine conditioned place preference. | Burgdorf CE et al. | β | 2020 | β |
| Dopamine Receptor DRD2 Gene rs1076560, Personality Traits and Anxiety in the Polysubstance Use Disorder. | Suchanecka A et al. | β | 2020 | β |
| Endogenous Opioids at the Intersection of Opioid Addiction, Pain, and Depression: The Search for a Precision Medicine Approach. | Emery MA et al. | β | 2020 | β |
| Facilitating Versus Inhibiting the Transmission of Drug Abuse from High-Risk Parents to Their Children: A Swedish National Study. | Kendler KS et al. | β | 2020 | β |
| Forecasting Opioid Use Disorder at 25Β Years of Age in 16-Year-Old Adolescents. | Tarter RE et al. | β | 2020 | β |
| Identification and Characterization of Biomarkers and Their Role in Opioid Addiction by Integrated Bioinformatics Analysis. | Zhang X et al. | β | 2020 | β |
| Impulsivity and Venturesomeness in an Adult ADHD Sample: Relation to Personality, Comorbidity, and Polygenic Risk. | Grimm O et al. | β | 2020 | β |
| Maternal Drinking and Child Emotional and Behavior Problems. | Lund IO et al. | β | 2020 | β |
| microRNA-422a Inhibits DCC Expression in a Manner Dependent on SNP rs12607853. | Li Y et al. | β | 2020 | β |
| Non-pharmacological factors that determine drug use and addiction. | Ahmed SH et al. | β | 2020 | β |
| Role of genetic background in the effects of adolescent nicotine exposure on mesolimbic dopamine transmission. | Cadoni C et al. | β | 2020 | β |
| Stratified analyses of genome wide association study data reveal haplotypes for a candidate gene on chromosome 2 (KIAA1211L) is associated with opioid use in patients of Arabian descent. | Alblooshi H et al. | β | 2020 | β |
| The Genetics of Externalizing Problems. | Barr PB et al. | β | 2020 | β |
| The Streetlight Effect: Reappraising the Study of Addiction in Light of the Findings of Genome-wide Association Studies. | Hall FS et al. | β | 2020 | β |
| Trajectories of cannabis use and risk for opioid misuse in a young adult urban cohort. | Reboussin BA et al. | β | 2020 | β |
| Tyrosine Hydroxylase Gene Polymorphisms Contribute to Opioid Dependence and Addiction by Affecting Promoter Region Function. | Liu JL et al. | β | 2020 | β |
| ΞΊ Opioid Receptor 1 Single Nucleotide Polymorphisms were Associated with the Methadone Dosage. | Zhang Q et al. | β | 2020 | β |
| Association between polygenic risk for tobacco or alcohol consumption and liability to licit and illicit substance use in young Australian adults. | Chang LH et al. | β | 2019 | β |
| Association of CamK2A genetic variants with transition time from occasional to regular heroin use in a sample of heroin-dependent individuals. | Eirich A et al. | β | 2019 | β |
| Effects of <i>CYP3A4</i> Polymorphisms on Drug Addiction Risk Among the Chinese Han Population. | Wang L et al. | β | 2019 | β |
| Genetic and environmental risk factors in the non-medical use of over-the-counter or prescribed analgesics, and their relationship to major classes of licit and illicit substance use and misuse in a population-based sample of young adult twins. | Gillespie NA et al. | β | 2019 | β |
| Genome-wide association study identifies loci associated with liability to alcohol and drug dependence that is associated with variability in reward-related ventral striatum activity in African- and European-Americans. | Wetherill L et al. | β | 2019 | β |
| Heroin versus cocaine: opposite choice as a function of context but not of drug history in the rat. | De Luca MT et al. | β | 2019 | β |
| Integrated Treatment of Adolescents with Co-occurring Depression and Substance Use Disorder. | Hinckley JD et al. | β | 2019 | β |
| <i>OPRM1</i> A118G Polymorphisms and Its Role in Opioid Addiction: Implication on Severity and Treatment Approaches. | Taqi MM et al. | β | 2019 | β |
| Lessons on Addiction Messages From "The Real Cost" Campaign. | Roditis ML et al. | β | 2019 | β |
| Management of opioid use disorder in the USA: present status and future directions. | Blanco C et al. | β | 2019 | β |
| Opioid Addiction, Genetic Susceptibility, and Medical Treatments: A Review. | Wang SC et al. | β | 2019 | β |
| Opposite environmental gating of the experienced utility ('liking') and decision utility ('wanting') of heroin versus cocaine in animals and humans: implications for computational neuroscience. | Badiani A et al. | β | 2019 | β |
| Relationships between substance abuse/dependence and psychiatric disorders based on polygenic scores. | GurriarΓ‘n X et al. | β | 2019 | β |
| Substance Use Disorder, Intravenous Injection, and HIV Infection: A Review. | Wang SC et al. | β | 2019 | β |
| Target-related parietal P3 and medial frontal theta index the genetic risk for problematic substance use. | Harper J et al. | β | 2019 | β |
| The Neuroscience of Drug Reward and Addiction. | Volkow ND et al. | β | 2019 | β |
| The spurious relationship between ecstasy use and neurocognitive deficits: A Bradford Hill review. | Amoroso T | β | 2019 | β |
| An analysis of genetic association in opioid dependence susceptibility. | Nagaya D et al. | β | 2018 | β |
| Associations Between Divorce and Onset of Drug Abuse in a Swedish National Sample. | Edwards AC et al. | β | 2018 | β |
| Associations between personality disorders and cannabis use and cannabis use disorder: a population-based twin study. | Gillespie NA et al. | β | 2018 | β |
| Associations Between the Dopamine D4 Receptor and DAT1 Dopamine Transporter Genes Polymorphisms and Personality Traits in Addicted Patients. | Chmielowiec J et al. | β | 2018 | β |
| Biospecimens and the ABCD study: Rationale, methods of collection, measurement and early data. | Uban KA et al. | β | 2018 | β |
| Cannabis consumption and psychosis or schizophrenia development. | Ortiz-Medina MB et al. | β | 2018 | β |
| Demographic and socioenvironmental predictors of premorbid marijuana use among patients with first-episode psychosis. | Pauselli L et al. | β | 2018 | β |
| Denise Kandel's classic work on the gateway sequence of drug acquisition. | Lynskey MT et al. | β | 2018 | β |
| Dissociable psychosocial profiles of adolescent substance users. | Fitzgerald A et al. | β | 2018 | β |
| Dopamine gene variants in opioid addiction: comparison of dependent patients, nondependent users and healthy controls. | Randesi M et al. | β | 2018 | β |
| Environmental, genetic and epigenetic contributions to cocaine addiction. | Pierce RC et al. | β | 2018 | β |
| Evaluation of prodynorphin gene polymorphisms and their association with heroin addiction in a sample of the southeast Iranian population. | Hashemi M et al. | β | 2018 | β |
| GABRA2, alcohol, and illicit drug use: An event-level model of genetic risk for polysubstance use. | Mallard TT et al. | β | 2018 | β |
| Genome wide analysis of rare copy number variations in alcohol abuse or dependence. | RodrΓguez-LΓ³pez J et al. | β | 2018 | β |
| Molecular Genetics and New Medication Strategies for Opioid Addiction. | Hurd YL et al. | β | 2018 | β |
| Novelty seeking mediates the effect of DRD3 variation on onset age of amphetamine dependence in Han Chinese population. | Kuo SC et al. | β | 2018 | β |
| OPRD1 Genetic Variation and Human Disease. | Crist RC et al. | β | 2018 | β |
| Overlap of heritable influences between cannabis use disorder, frequency of use and opportunity to use cannabis: trivariate twin modelling and implications for genetic design. | Hines LA et al. | β | 2018 | β |
| Post-GWAS in Psychiatric Genetics: A Developmental Perspective on the "Other" Next Steps. | Dick DM et al. | β | 2018 | β |
| Prediction of drug abuse recurrence: a Swedish National Study. | Kendler KS et al. | β | 2018 | β |
| The gene-environmental architecture of the development of adolescent substance use. | Vitaro F et al. | β | 2018 | β |
| Transition to drug co-use among adolescent cannabis users: The role of decision-making and mental health. | Lopez-Quintero C et al. | β | 2018 | β |
| A brief review of the genetics and pharmacogenetics of opioid use disorders. | Berrettini W | β | 2017 | β |
| DNA Methylation Profiling of Human Prefrontal Cortex Neurons in Heroin Users Shows Significant Difference between Genomic Contexts of Hyper- and Hypomethylation and a Younger Epigenetic Age. | Kozlenkov A et al. | β | 2017 | β |
| DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample. | Hayley AC et al. | β | 2017 | β |
| Executive functions and substance use: Relations in late adolescence and early adulthood. | Gustavson DE et al. | β | 2017 | β |
| Family history of alcoholism is related to increased D<sub>2</sub> /D<sub>3</sub> receptor binding potential: a marker of resilience or risk? | Alvanzo AA et al. | β | 2017 | β |
| Genetic moderation of cocaine subjective effects by variation in the TPH1, TPH2, and SLC6A4 serotonin genes. | Patriquin MA et al. | β | 2017 | β |
| Genetic polymorphisms in ALDH2 are associated with drug addiction in a Chinese Han population. | Zhang C et al. | β | 2017 | β |
| Heritability of lifetime ecstasy use. | Verweij KJH et al. | β | 2017 | β |
| The Decomposition of Shared Environmental Influences on Externalizing Syndromes in the Swedish Population: A Multivariate Study. | Ohlsson H et al. | β | 2017 | β |
| Age at first use and later substance use disorder: Shared genetic and environmental pathways for nicotine, alcohol, and cannabis. | Richmond-Rakerd LS et al. | β | 2016 | β |
| A Population-Based Study of Four Genes Associated with Heroin Addiction in Han Chinese. | Li Y et al. | β | 2016 | β |
| A Review of Genome-Wide Association Studies of Stimulant and Opioid Use Disorders. | Jensen KP | β | 2016 | β |
| Assessment and characterization of phenotypic heterogeneity of anxiety disorders across five large cohorts. | Lee M et al. | β | 2016 | β |
| Association between serotonin transporter gene polymorphisms and heroin dependence: a meta-analytic study. | Lin PY et al. | β | 2016 | β |
| CYP gene family variants as potential protective factors in drug addiction in Han Chinese. | Zhang H et al. | β | 2016 | β |
| Evidence of CNIH3 involvement in opioid dependence. | Nelson EC et al. | β | 2016 | β |
| Exposure to opiates in female adolescents alters mu opiate receptor expression and increases the rewarding effects of morphine in future offspring. | Vassoler FM et al. | β | 2016 | β |
| Genome-Wide Association of Heroin Dependence in Han Chinese. | Kalsi G et al. | β | 2016 | β |
| Influence of the A118G Polymorphism of the OPRM1 Gene and Exon 3 VNTR Polymorphism of the DRD4 Gene on Cigarette Craving After Alcohol Administration. | Lechner WV et al. | β | 2016 | β |
| Item Response Theory Analysis to Assess Dimensionality of Substance Use Disorder Abuse and Dependence Symptoms. | Kirisci L et al. | β | 2016 | β |
| KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex. | Johnson EO et al. | β | 2016 | β |
| Machine-learning identifies substance-specific behavioral markers for opiate and stimulant dependence. | Ahn WY et al. | β | 2016 | β |
| Nicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug use. | Melroy-Greif WE et al. | β | 2016 | β |
| Novelty Seeking and Drug Addiction in Humans and Animals: From Behavior to Molecules. | Wingo T et al. | β | 2016 | β |
| Opioid Use Disorders. | Sharma B et al. | β | 2016 | β |
| Psychometric modeling of abuse and dependence symptoms across six illicit substances indicates novel dimensions of misuse. | Clark SL et al. | β | 2016 | β |
| Safety concerns with long-term opioid use. | Harned M et al. | β | 2016 | β |
| The relationship between polymorphisms of BDNFOS and BDNF genes and heroin addiction in the Han Chinese population. | Jin T et al. | β | 2016 | β |
| Tobacco and alcohol use among adolescents in South Africa: shared and unshared risks. | Morojele NK et al. | β | 2016 | β |
| Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence. | Randesi M et al. | β | 2016 | β |
| Which adolescents develop persistent substance dependence in adulthood? Using population-representative longitudinal data to inform universal risk assessment. | Meier MH et al. | β | 2016 | β |
| Adolescent drinking and brain morphometry: A co-twin control analysis. | Wilson S et al. | β | 2015 | β |
| An animal model of differential genetic risk for methamphetamine intake. | Phillips TJ et al. | β | 2015 | β |
| A population-based Swedish Twin and Sibling Study of cannabis, stimulant and sedative abuse in men. | Kendler KS et al. | β | 2015 | β |
| Association between contraband tobacco and illicit drug use among high school students in Canada. | Azagba S et al. | β | 2015 | β |
| Association of substance dependence phenotypes in the COGA sample. | Wetherill L et al. | β | 2015 | β |
| Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1. | Hancock DB et al. | β | 2015 | β |
| Examining the role of common genetic variants on alcohol, tobacco, cannabis and illicit drug dependence: genetics of vulnerability to drug dependence. | Palmer RH et al. | β | 2015 | β |
| Exposure to peer deviance during childhood and risk for drug abuse: a Swedish national co-relative control study. | Kendler KS et al. | β | 2015 | β |
| Externalizing behavior and emotion dysregulation are indicators of transmissible risk for substance use disorder. | Kirisci L et al. | β | 2015 | β |
| Eyes on the price: Human culture and its teaching. | MΓΌller CP | β | 2015 | β |
| Family history density predicts long term substance use outcomes in an adolescent treatment sample. | Khoddam R et al. | β | 2015 | β |
| GABRB2 Haplotype Association with Heroin Dependence in Chinese Population. | Kim YS et al. | β | 2015 | β |
| Genetic and Environmental Interplay in Adolescent Substance Use Disorders. | Hines LA et al. | β | 2015 | β |
| Genetic relationship between the addiction diagnosis in adults and their childhood measure of addiction liability. | Vanyukov M et al. | β | 2015 | β |
| Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders. | Brewer AJ et al. | β | 2015 | β |
| Introduction to the special issue: Substance use and the adolescent brain: Developmental impacts, interventions, and longitudinal outcomes. | Luciana M et al. | β | 2015 | β |
| Longitudinal Modeling of the Association Between Transmissible Risk, Affect During Drug Use and Development of Substance Use Disorder. | Tarter RE et al. | β | 2015 | β |
| Multigenerational and transgenerational inheritance of drug exposure: The effects of alcohol, opiates, cocaine, marijuana, and nicotine. | Yohn NL et al. | β | 2015 | β |
| Part III: Principal component analysis: bridging the gap between strain, sex and drug effects. | Keeley RJ et al. | β | 2015 | β |
| Probability and predictors of the cannabis gateway effect: a national study. | Secades-Villa R et al. | β | 2015 | β |
| Risk for behavior problems in children of parents with substance use disorders. | Bountress K et al. | β | 2015 | β |
| Smoking and schizophrenia in population cohorts of Swedish women and men: a prospective co-relative control study. | Kendler KS et al. | β | 2015 | β |
| Strain dependence of adolescent Cannabis influence on heroin reward and mesolimbic dopamine transmission in adult Lewis and Fischer 344 rats. | Cadoni C et al. | β | 2015 | β |
| The Power of Theory, Research Design, and Transdisciplinary Integration in Moving Psychopathology Forward. | Vaidyanathan U et al. | β | 2015 | β |
| The prospective association between sipping alcohol by the sixth grade and later substance use. | Jackson KM et al. | β | 2015 | β |
| The role of conduct disorder in the relationship between alcohol, nicotine and cannabis use disorders. | Grant JD et al. | β | 2015 | β |
| Altitude may contribute to regional variation in methamphetamine use in the United States: a population database study. | Kim TS et al. | β | 2014 | β |
| A new approach to researching the etiology of cannabis use disorder: integrating transmissible and nontransmissible risk within a developmental framework. | Tarter R et al. | β | 2014 | β |
| A population-based association study of casein kinase 1 epsilon loci with heroin dependence in Han Chinese. | Wang Y et al. | β | 2014 | β |
| Association of the HTR2A gene with alcohol and heroin abuse. | Cao J et al. | β | 2014 | β |
| Associations between childhood abuse and interpersonal aggression and suicide attempt among U.S. adults in a national study. | Harford TC et al. | β | 2014 | β |
| Curious cases: Altered dose-response relationships in addiction genetics. | Uhl GR et al. | β | 2014 | β |
| DRD3 variation associates with early-onset heroin dependence, but not specific personality traits. | Kuo SC et al. | β | 2014 | β |
| Drug addiction and stress-response genetic variability: association study in African Americans. | Levran O et al. | β | 2014 | β |
| Drug addiction in pregnancy: disease not moral failure. | Maguire D | β | 2014 | β |
| Drug specificity in drug versus food choice in male rats. | Tunstall BJ et al. | β | 2014 | β |
| Genetic and environmental risk factors for illicit substance use and use disorders: Joint analysis of self and co-twin ratings. | Ystrom E et al. | β | 2014 | β |
| Have the genetics of cannabis involvement gone to pot? | Agrawal A et al. | β | 2014 | β |
| Identifying childhood characteristics that underlie premorbid risk for substance use disorders: socialization and boldness. | Hicks BM et al. | β | 2014 | β |
| Is a 'general' theory of addiction possible? A commentary on: a multistep general theory of transition to addiction. | Badiani A | β | 2014 | β |
| Mu opioid receptor gene: new point mutations in opioid addicts. | Dinarvand A et al. | β | 2014 | β |
| Negative emotionality mediates the association of 5-HTTLPR genotype and depression in children with and without ADHD. | Li JJ et al. | β | 2014 | β |
| Rare nonsynonymous exonic variants in addiction and behavioral disinhibition. | Vrieze SI et al. | β | 2014 | β |
| Reduced dopamine response to amphetamine in subjects at ultra-high risk for addiction. | Casey KF et al. | β | 2014 | β |
| Testing the drug substitution switching-addictions hypothesis. A prospective study in a nationally representative sample. | Blanco C et al. | β | 2014 | β |
| The role of the opioid system in alcohol dependence. | Nutt DJ | β | 2014 | β |
| Analyzing Interaction of ΞΌ-, Ξ΄- and ΞΊ-opioid Receptor Gene Variants on Alcohol or Drug Dependence Using a Pattern Discovery-based Method. | Li Z et al. | β | 2013 | β |
| ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: importance of considering drug exposure. | Nelson EC et al. | β | 2013 | β |
| Are addictions diseases or choices? | Leyton M | β | 2013 | β |
| Association between DRD2, 5-HTTLPR, and ALDH2 genes and specific personality traits in alcohol- and opiate-dependent patients. | Wang TY et al. | β | 2013 | β |
| Case-control association analysis of polymorphisms in the Ξ΄-opioid receptor, OPRD1, with cocaine and opioid addicted populations. | Crist RC et al. | β | 2013 | β |
| Case-control association study of WLS variants in opioid and cocaine addicted populations. | Crist RC et al. | β | 2013 | β |
| Epigenetic inheritance of a cocaine-resistance phenotype. | Vassoler FM et al. | β | 2013 | β |
| Four factors for the initiation of substance use by young adulthood: a 10-year follow-up twin and sibling study of marital conflict, monitoring, siblings, and peers. | Neiderhiser JM et al. | β | 2013 | β |
| Is ADHD a risk factor independent of conduct disorder for illicit substance use? A meta-analysis and metaregression investigation. | Serra-Pinheiro MA et al. | β | 2013 | β |
| Is the relationship between early-onset cannabis use and educational attainment causal or due to common liability? | Verweij KJ et al. | β | 2013 | β |
| Longitudinal modeling of transmissible risk in boys who subsequently develop cannabis use disorder. | Kirisci L et al. | β | 2013 | β |
| Long-term CBβ receptor blockade enhances vulnerability to anxiogenic-like effects of cannabinoids. | Tambaro S et al. | β | 2013 | β |
| Low frequency genetic variants in the ΞΌ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine. | Clarke TK et al. | β | 2013 | β |
| Multivariate analysis of dopaminergic gene variants as risk factors of heroin dependence. | Vereczkei A et al. | β | 2013 | β |
| Neuroadaptive changes associated with smoking: structural and functional neural changes in nicotine dependence. | Martin-Soelch C | β | 2013 | β |
| Other- and self-directed forms of violence and their relationships to DSM-IV substance use and other psychiatric disorders in a national survey of adults. | Harford TC et al. | β | 2013 | β |
| Predominant typologies of psychopathology in the United States: a latent class analysis. | El-Gabalawy R et al. | β | 2013 | β |
| Relation among HPA and HPG neuroendocrine systems, transmissible risk and neighborhood quality on development of substance use disorder: results of a 10-year prospective study. | Tarter RE et al. | β | 2013 | β |
| Shattered childhoods and the genetics of heroin dependence. | Agrawal A et al. | β | 2013 | β |
| Substance-specific environmental influences on drug use and drug preference in animals and humans. | Badiani A | β | 2013 | β |
| Three mutually informative ways to understand the genetic relationships among behavioral disinhibition, alcohol use, drug use, nicotine use/dependence, and their co-occurrence: twin biometry, GCTA, and genome-wide scoring. | Vrieze SI et al. | β | 2013 | β |
| Application of person-centered medicine in addiction. | Tarter RE et al. | β | 2012 | β |
| Are the symptoms of cannabis use disorder best accounted for by dimensional, categorical, or factor mixture models? A comparison of male and female young adults. | Gillespie NA et al. | β | 2012 | β |
| Association study of the Ξ²-arrestin 2 gene (ARRB2) with opioid and cocaine dependence in a European-American population. | Ambrose-Lanci LM et al. | β | 2012 | β |
| Autosomal linkage scan for loci predisposing to comorbid dependence on multiple substances. | Yang BZ et al. | β | 2012 | β |
| Behavioral inhibition in mice bred for high vs. low levels of methamphetamine consumption or sensitization. | Moschak TM et al. | β | 2012 | β |
| Cocaine use in the past year is associated with altitude of residence. | Fiedler KK et al. | β | 2012 | β |
| Cognitive dysfunction and anxious-impulsive personality traits are endophenotypes for drug dependence. | Ersche KD et al. | β | 2012 | β |
| Common and specific liability to addiction: approaches to association studies of opioid addiction. | Nielsen DA et al. | β | 2012 | β |
| Common liability to addiction and "gateway hypothesis": theoretical, empirical and evolutionary perspective. | Vanyukov MM et al. | β | 2012 | β |
| Confluence of genes, environment, development, and behavior in a post Genome-Wide Association Study world. | Vrieze SI et al. | β | 2012 | β |
| Decline in genetic influence on the co-occurrence of alcohol, marijuana, and nicotine dependence symptoms from age 14 to 29. | Vrieze SI et al. | β | 2012 | β |
| Developmental trajectories of substance use from early adolescence to young adulthood: gender and racial/ethnic differences. | Chen P et al. | β | 2012 | β |
| Does the "gateway" sequence increase prediction of cannabis use disorder development beyond deviant socialization? Implications for prevention practice and policy. | Tarter RE et al. | β | 2012 | β |
| Epidemiology of substance use disorders. | Merikangas KR et al. | β | 2012 | β |
| Externalizing behaviors are associated with SNPs in the CHRNA5/CHRNA3/CHRNB4 gene cluster. | Stephens SH et al. | β | 2012 | β |
| Genetic and environmental influences underlying externalizing behaviors, cigarette smoking and illicit drug use across adolescence. | Korhonen T et al. | β | 2012 | β |
| Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction. | Clarke TK et al. | β | 2012 | β |
| Genetic factors modulating the response to stimulant drugs in humans. | Hart AB et al. | β | 2012 | β |
| Genome-wide linkage scan of antisocial behavior, depression, and impulsive substance use in the UCSF family alcoholism study. | Gizer IR et al. | β | 2012 | β |
| Imaging genetics and the neurobiological basis of individual differences in vulnerability to addiction. | Sweitzer MM et al. | β | 2012 | β |
| Improved methods to identify stable, highly heritable subtypes of opioid use and related behaviors. | Sun J et al. | β | 2012 | β |
| Index of the transmissible common liability to addiction: heritability and prospective associations with substance abuse and related outcomes. | Hicks BM et al. | β | 2012 | β |
| Nerve growth factor Ξ² polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment. | Levran O et al. | β | 2012 | β |
| Prenatal cigarette smoke exposure and early initiation of multiple substance use. | Goldschmidt L et al. | β | 2012 | β |
| Recent advances in the genetic epidemiology and molecular genetics of substance use disorders. | Kendler KS et al. | β | 2012 | β |
| Revisiting the concepts of risk and protective factors for understanding the etiology and development of substance use and substance use disorders: implications for prevention. | Sloboda Z et al. | β | 2012 | β |
| Shared environmental contributions to substance use. | Baker JH et al. | β | 2012 | β |
| Stimulant use disorders: characteristics and comorbidity in an Australian population sample. | Sara G et al. | β | 2012 | β |
| Subjective effects for alcohol, tobacco, and marijuana association with cross-drug outcomes. | Zeiger JS et al. | β | 2012 | β |
| Substance use disorders and adoption: findings from a national sample. | Yoon G et al. | β | 2012 | β |
| Sulpiride, but not SCH23390, modifies cocaine-induced conditioned place preference and expression of tyrosine hydroxylase and elongation factor 1Ξ± in zebrafish. | Darland T et al. | β | 2012 | β |
| The effects of childhood ADHD symptoms on early-onset substance use: a Swedish twin study. | Chang Z et al. | β | 2012 | β |
| The genetics of addiction-a translational perspective. | Agrawal A et al. | β | 2012 | β |
| The interplay of genes and adolescent development in substance use disorders: leveraging findings from GWAS meta-analyses to test developmental hypotheses about nicotine consumption. | Vrieze SI et al. | β | 2012 | β |
| Variation in regulator of G-protein signaling 17 gene (RGS17) is associated with multiple substance dependence diagnoses. | Zhang H et al. | β | 2012 | β |
| What does self-identified drug of choice tell us about individuals under community corrections supervision? | Clark BC et al. | β | 2012 | β |
| Association between heroin dependence and prodynorphin gene polymorphisms. | Wei SG et al. | β | 2011 | β |
| Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia. | Ho BC et al. | β | 2011 | β |
| Common and drug-specific genetic influences on subjective effects to alcohol, tobacco and marijuana use. | Haberstick BC et al. | β | 2011 | β |
| Could a continuous measure of individual transmissible risk be useful in clinical assessment of substance use disorder? Findings from the National Epidemiological Survey on Alcohol and Related Conditions. | Ridenour TA et al. | β | 2011 | β |
| Deviant socialization mediates transmissible and contextual risk on cannabis use disorder development: a prospective study. | Tarter RE et al. | β | 2011 | β |
| Disordered gambling: etiology, trajectory, and clinical considerations. | Shaffer HJ et al. | β | 2011 | β |
| Drugs as instruments: a new framework for non-addictive psychoactive drug use. | MΓΌller CP et al. | β | 2011 | β |
| Elevated levels of DNA methylation at the OPRM1 promoter in blood and sperm from male opioid addicts. | Chorbov VM et al. | β | 2011 | β |
| Homeostatic control of neural activity: a Drosophila model for drug tolerance and dependence. | Ghezzi A et al. | β | 2011 | β |
| Imaging brain response to reward in addictive disorders. | Hommer DW et al. | β | 2011 | β |
| Inter-rater reliability and concurrent validity of DSM-IV opioid dependence in a Hmong isolate using the Thai version of the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA). | Malison RT et al. | β | 2011 | β |
| Linkage analyses of stimulant dependence, craving, and heavy use in American Indians. | Ehlers CL et al. | β | 2011 | β |
| Molecular targets of alcohol action: Translational research for pharmacotherapy development and screening. | Gorini G et al. | β | 2011 | β |
| Opiate versus psychostimulant addiction: the differences do matter. | Badiani A et al. | β | 2011 | β |
| Opioid dependence. | Praveen KT et al. | β | 2011 | β |
| Psychometric modeling of cannabis initiation and use and the symptoms of cannabis abuse, dependence and withdrawal in a sample of male and female twins. | Gillespie NA et al. | β | 2011 | β |
| Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood. | Nemoda Z et al. | β | 2011 | β |
| Role of novelty seeking personality traits as mediator of the association between COMT and onset age of drug use in Chinese heroin dependent patients. | Li T et al. | β | 2011 | β |
| Sex differences and developmental stability in genetic and environmental influences on psychoactive substance consumption from early adolescence to young adulthood. | Baker JH et al. | β | 2011 | β |
| The AVPR1A gene and substance use disorders: association, replication, and functional evidence. | Maher BS et al. | β | 2011 | β |
| Use of item response theory and latent class analysis to link poly-substance use disorders with addiction severity, HIV risk, and quality of life among opioid-dependent patients in the Clinical Trials Network. | Wu LT et al. | β | 2011 | β |
| A cotwin-control analysis of drug use and abuse/dependence risk associated with early-onset cannabis use. | Grant JD et al. | β | 2010 | β |
| Addictions and their familiality in Iceland. | Tyrfingsson T et al. | β | 2010 | β |
| Association of functional variants in the dopamine D2-like receptors with risk for gambling behaviour in healthy Caucasian subjects. | Lobo DS et al. | β | 2010 | β |
| Association of VNTR polymorphisms in the MAOA promoter and DRD4 exon 3 with heroin dependence in male Chinese addicts. | Chien CC et al. | β | 2010 | β |
| Cluster A Personality Disorders: Schizotypal, Schizoid and Paranoid Personality Disorders in Childhood and Adolescence. | Esterberg ML et al. | β | 2010 | β |
| Consilient research approaches in studying gene x environment interactions in alcohol research. | Sher KJ et al. | β | 2010 | β |
| Do candidate genes discriminate patients with an autism spectrum disorder from those with attention deficit/hyperactivity disorder and is there an effect of lifetime substance use disorders? | Sizoo B et al. | β | 2010 | β |
| Eating disorder symptomatology and substance use disorders: prevalence and shared risk in a population based twin sample. | Baker JH et al. | β | 2010 | β |
| Evidence for association of two variants of the nociceptin/orphanin FQ receptor gene OPRL1 with vulnerability to develop opiate addiction in Caucasians. | Briant JA et al. | β | 2010 | β |
| Genetic and environmental influences on cannabis use initiation and problematic use: a meta-analysis of twin studies. | Verweij KJ et al. | β | 2010 | β |
| Genetic and environmental risk factors for adolescent-onset substance use disorders. | Meyers JL et al. | β | 2010 | β |
| Genetics of drug dependence. | Gelernter J et al. | β | 2010 | β |
| Genome-wide association study identifies genes that may contribute to risk for developing heroin addiction. | Nielsen DA et al. | β | 2010 | β |
| Khat use and neurobehavioral functions: suggestions for future studies. | Hoffman R et al. | β | 2010 | β |
| Linkage analyses of cannabis dependence, craving, and withdrawal in the San Francisco family study. | Ehlers CL et al. | β | 2010 | β |
| Measuring addiction propensity and severity: the need for a new instrument. | Conway KP et al. | β | 2010 | β |
| Mechanisms underlying the lifetime co-occurrence of tobacco and cannabis use in adolescent and young adult twins. | Agrawal A et al. | β | 2010 | β |
| Modeling the impact of age and sex on a dimension of poly-substance use in adolescence: a longitudinal study from 11- to 17-years-old. | Derringer J et al. | β | 2010 | β |
| Neither single-marker nor haplotype analyses support an association between the dopamine transporter gene and heroin dependence in Han Chinese. | Yeh YW et al. | β | 2010 | β |
| Parental consanguinity and susceptibility to drug abuse among offspring, a case-control study. | Saadat M et al. | β | 2010 | β |
| Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependence. | Bousman CA et al. | β | 2010 | β |
| Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction. | Deb I et al. | β | 2010 | β |
| The influence of GABRA2, childhood trauma, and their interaction on alcohol, heroin, and cocaine dependence. | Enoch MA et al. | β | 2010 | β |
| The influence of the comorbidity between depression and alcohol use disorder on suicidal behaviors in the SΓ£o Paulo Epidemiologic Catchment Area Study, Brazil. | CoΓͺlho BM et al. | β | 2010 | β |
| An association of prodynorphin polymorphisms and opioid dependence in females in a Chinese population. | Clarke TK et al. | β | 2009 | β |
| Approaching the genomics of risk-taking behavior. | Bell AM | β | 2009 | β |
| Association of variants in MANEA with cocaine-related behaviors. | Farrer LA et al. | β | 2009 | β |
| Developmental processes and mechanisms: ages 0-10. | Zucker RA et al. | β | 2009 | β |
| From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics. | Chu LF et al. | β | 2009 | β |
| Genetic association studies of methamphetamine use disorders: A systematic review and synthesis. | Bousman CA et al. | β | 2009 | β |
| Genetic investigation of race and addiction. | Freedman R | β | 2009 | β |
| Measurement of the risk for substance use disorders: phenotypic and genetic analysis of an index of common liability. | Vanyukov MM et al. | β | 2009 | β |
| Modeling the genetic and environmental association between peer group deviance and cannabis use in male twins. | Gillespie NA et al. | β | 2009 | β |
| Mouse model of relapse to the abuse of drugs: procedural considerations and characterizations. | Yan Y et al. | β | 2009 | β |
| Opioid dependence. | O'Shea J et al. | β | 2009 | β |
| Perceived peer delinquency and the genetic predisposition for substance dependence vulnerability. | Button TM et al. | β | 2009 | β |
| Role of GABRA2 on risk for alcohol, nicotine, and cannabis dependence in the Iowa Adoption Studies. | Philibert RA et al. | β | 2009 | β |
| Tolerance in Drosophila. | Atkinson NS | β | 2009 | β |
| Are there genetic influences on addiction: evidence from family, adoption and twin studies. | Agrawal A et al. | β | 2008 | β |
| A retrospective sibling study of childhood adjustment in adults with substance use disorders. | Easow JM et al. | β | 2008 | β |
| A risk allele for nicotine dependence in CHRNA5 is a protective allele for cocaine dependence. | Grucza RA et al. | β | 2008 | β |
| Association between heroin dependence and 5-HT2A receptor gene polymorphisms. | SΓ‘iz PA et al. | β | 2008 | β |
| Association between the Stin2 VNTR polymorphism of the serotonin transporter gene and treatment outcome in alcohol-dependent patients. | Florez G et al. | β | 2008 | β |
| Attention deficit hyperactivity disorder and substance use disorders. | Szobot CM et al. | β | 2008 | β |
| Autosomal linkage analysis for cannabis use behaviors in Australian adults. | Agrawal A et al. | β | 2008 | β |
| Behavioral disinhibition and the development of early-onset addiction: common and specific influences. | Iacono WG et al. | β | 2008 | β |
| Cannabinoid receptor 1 gene association with nicotine dependence. | Chen X et al. | β | 2008 | β |
| Drug use and dependence in cocaine dependent subjects, community-based individuals, and their siblings. | Bierut LJ et al. | β | 2008 | β |
| Early developmental processes and the continuity of risk for underage drinking and problem drinking. | Zucker RA et al. | β | 2008 | β |
| Evidence for a two-stage model of dependence using the NESARC and its implications for genetic association studies. | Heiman GA et al. | β | 2008 | β |
| Familial transmission of derived phenotypes for molecular genetic studies of substance use disorders. | Faraone SV et al. | β | 2008 | β |
| Forum: Decriminalization of cannabis. | van den Brink W | β | 2008 | β |
| Genes and molecules that can potentiate or attenuate psychostimulant dependence: relevance of data from animal models to human addiction. | Niwa M et al. | β | 2008 | β |
| Genetic factors influencing alcohol dependence. | Mayfield RD et al. | β | 2008 | β |
| Genetic susceptibility to heroin addiction: a candidate gene association study. | Levran O et al. | β | 2008 | β |
| Genotype patterns that contribute to increased risk for or protection from developing heroin addiction. | Nielsen DA et al. | β | 2008 | β |
| Is there evidence for symptoms of cannabis withdrawal in the national epidemiologic survey of alcohol and related conditions? | Agrawal A et al. | β | 2008 | β |
| Linkage scan for quantitative traits identifies new regions of interest for substance dependence in the Collaborative Study on the Genetics of Alcoholism (COGA) sample. | Agrawal A et al. | β | 2008 | β |
| Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes. | Haughey HM et al. | β | 2008 | β |
| Neurobiology of addiction. An integrative review. | Goodman A | β | 2008 | β |
| Physical maturation, peer environment, and the ontogenesis of substance use disorders. | Kirillova GP et al. | β | 2008 | β |
| Socioeconomic status and social support following illicit drug use: causal pathways or common liability? | Bergen SE et al. | β | 2008 | β |
| Substance dependence low-density whole genome association study in two distinct American populations. | Yu Y et al. | β | 2008 | β |
| The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia? | DeLisi LE | β | 2008 | β |
| The genetics of alcohol and other drug dependence. | Dick DM et al. | β | 2008 | β |
| The role of 5-HT3 receptors in drug abuse and as a target for pharmacotherapy. | Engleman EA et al. | β | 2008 | β |
| The validity of cocaine dependence subtypes. | Kranzler HR et al. | β | 2008 | β |
| A genome-wide scan for loci influencing adolescent cannabis dependence symptoms: evidence for linkage on chromosomes 3 and 9. | Hopfer CJ et al. | β | 2007 | β |
| A latent class analysis of illicit drug abuse/dependence: results from the National Epidemiological Survey on Alcohol and Related Conditions. | Agrawal A et al. | β | 2007 | β |
| Allelic and genotypic associations of DRD2 TaqI A polymorphism with heroin dependence in Spanish subjects: a case control study. | Perez de los Cobos J et al. | β | 2007 | β |
| Cause-specific excess mortality in siblings of patients co-infected with HIV and hepatitis C virus. | Hansen AB et al. | β | 2007 | β |
| CNR1 variation modulates risk for drug and alcohol dependence. | Zuo L et al. | β | 2007 | β |
| Deriving phenotypes for molecular genetic studies of substance use disorders: a family study approach. | Faraone SV et al. | β | 2007 | β |
| Enduring vulnerability to reinstatement of methamphetamine-seeking behavior in glial-cell-line-derived neurotrophic factor mutant mice. | Yan Y et al. | β | 2007 | β |
| Factor and item-response analysis DSM-IV criteria for abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, stimulants and opioids. | Gillespie NA et al. | β | 2007 | β |
| Genes mediate the association between P3 amplitude and externalizing disorders. | Hicks BM et al. | β | 2007 | β |
| Genomewide suggestive linkage of opioid dependence to chromosome 14q. | Lachman HM et al. | β | 2007 | β |
| Longitudinal modeling of genetic and environmental influences on self-reported availability of psychoactive substances: alcohol, cigarettes, marijuana, cocaine and stimulants. | Gillespie NA et al. | β | 2007 | β |
| Multiple ADH genes modulate risk for drug dependence in both African- and European-Americans. | Luo X et al. | β | 2007 | β |
| Opioid dependence and addiction during opioid treatment of chronic pain. | Ballantyne JC et al. | β | 2007 | β |
| Prodynorphin gene promoter repeat associated with cocaine/alcohol codependence. | Williams TJ et al. | β | 2007 | β |
| Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid self-administration in rats. | Deiana S et al. | β | 2007 | β |
| Substance use disorder (SUD) morbidity versus number of parents with SUD. | Westermeyer J et al. | β | 2007 | β |
| The latent structure of marijuana and cocaine use disorders: results from the National Longitudinal Alcohol Epidemiologic Survey (NLAES). | Blanco C et al. | β | 2007 | β |
| The MAOA promoter polymorphism, disruptive behavior disorders, and early onset substance use disorder: gene-environment interaction. | Vanyukov MM et al. | β | 2007 | β |
| Trajectories of adolescent alcohol and cannabis use into young adulthood. | Patton GC et al. | β | 2007 | β |
| An overview of the genetics of substance use disorders. | Lachman HM | β | 2006 | β |
| Application of item response theory to quantify substance use disorder severity. | Kirisci L et al. | β | 2006 | β |
| Association of GABRA2 with drug dependence in the collaborative study of the genetics of alcoholism sample. | Agrawal A et al. | β | 2006 | β |
| Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents. | Hopfer CJ et al. | β | 2006 | β |
| Ecstasy and the antecedents of illicit drug use. | Poikolainen K | β | 2006 | β |
| Examination of the causes of covariation between conduct disorder symptoms and vulnerability to drug dependence. | Button TM et al. | β | 2006 | β |
| Family based association analysis of statistically derived quantitative traits for drug use in ADHD and the dopamine transporter gene. | Lasky-Su J et al. | β | 2006 | β |
| Genetic and environmental vulnerabilities underlying adolescent substance use and problem use: general or specific? | Young SE et al. | β | 2006 | β |
| Genomewide linkage scan for opioid dependence and related traits. | Gelernter J et al. | β | 2006 | β |
| Is there heterogeneity among syndromes of substance use disorder for illicit drugs? | Beseler C et al. | β | 2006 | β |
| Linking substance use and problem behavior across three generations. | Bailey JA et al. | β | 2006 | β |
| Predictors of marijuana use in adolescents before and after licit drug use: examination of the gateway hypothesis. | Tarter RE et al. | β | 2006 | β |
| Psychiatric comorbidity and progression in drug use in adult male twins: implications for the design of genetic association studies. | Todorov AA et al. | β | 2006 | β |
| Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10). | Hasin D et al. | β | 2006 | β |
| Substance use disorder trajectory classes: diachronic integration of onset age, severity, and course. | Clark DB et al. | β | 2006 | β |
| Subtypes of illicit drug users: a latent class analysis of data from an Australian twin sample. | Lynskey MT et al. | β | 2006 | β |
| Symbiotic relationship of pharmacogenetics and drugs of abuse. | Rutter JL | β | 2006 | β |
| The genetic epidemiology of cannabis use, abuse and dependence. | Agrawal A et al. | β | 2006 | β |
| The nature of genetic influences on behavior: lessons from "simpler" organisms. | Kendler KS et al. | β | 2006 | β |
| The relationship between crystalline methamphetamine use and methamphetamine dependence. | McKetin R et al. | β | 2006 | β |
| "A gene for...": the nature of gene action in psychiatric disorders. | Kendler KS | β | 2005 | β |
| Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity. | Wilens TE et al. | β | 2005 | β |
| Combining research approaches to advance our understanding of drug addiction. | van den Bree MB | β | 2005 | β |
| Detection of youth at high risk for substance use disorders: a longitudinal study. | Kirisci L et al. | β | 2005 | β |
| Developments in the epidemiology of drug use and drug use disorders. | Compton WM et al. | β | 2005 | β |
| Gene expression differences in mice divergently selected for methamphetamine sensitivity. | Palmer AA et al. | β | 2005 | β |
| Genetic determinants of addiction to opioids and cocaine. | Saxon AJ et al. | β | 2005 | β |
| Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. | Kreek MJ et al. | β | 2005 | β |
| Genomewide linkage scan for cocaine dependence and related traits: significant linkages for a cocaine-related trait and cocaine-induced paranoia. | Gelernter J et al. | β | 2005 | β |
| Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs. | Hall WD et al. | β | 2005 | β |
| Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. | Kreek MJ et al. | β | 2005 | β |
| Sensitivity to psychostimulants in mice bred for high and low stimulation to methamphetamine. | Kamens HM et al. | β | 2005 | β |
| The differential impact of risk factors on illicit drug involvement in females. | Agrawal A et al. | β | 2005 | β |
| The genetics of addictions: uncovering the genes. | Goldman D et al. | β | 2005 | β |
| Cannabis and other illicit drugs: comorbid use and abuse/dependence in males and females. | Agrawal A et al. | β | 2004 | β |
| Decreased absolute amygdala volume in cocaine addicts. | Makris N et al. | β | 2004 | β |
| Forms of cannabis and cocaine: a twin study. | Agrawal A et al. | β | 2004 | β |
| Gene-environment interplay in alcoholism and other substance abuse disorders: expressions of heritability and factors influencing vulnerability. | Palomo T et al. | β | 2004 | β |
| Genes associated with addiction: alcoholism, opiate, and cocaine addiction. | Kreek MJ et al. | β | 2004 | β |
| Haplotypes of the monoamine oxidase genes and the risk for substance use disorders. | Vanyukov MM et al. | β | 2004 | β |
| Relation between cognitive distortions and neurobehavior disinhibition on the development of substance use during adolescence and substance use disorder by young adulthood: a prospective study. | Kirisci L et al. | β | 2004 | β |
| Sleep problems in early childhood and early onset of alcohol and other drug use in adolescence. | Wong MM et al. | β | 2004 | β |
| The epidemiology of dual diagnosis. | Kessler RC | β | 2004 | β |
| The risk for mild kidney function decline associated with illicit drug use among hypertensive men. | Vupputuri S et al. | β | 2004 | β |
| Toward a syndrome model of addiction: multiple expressions, common etiology. | Shaffer HJ et al. | β | 2004 | β |
| Liability to substance use disorders: 1. Common mechanisms and manifestations. | Vanyukov MM et al. | β | 2003 | β |